1. Comparison of the Performance of the CepheidXpert HemosILFactor II and Factor V and the ViennaLabFV-PTH-MTHFRStripAssay Kits for Molecular Thrombophilia Profiling
- Author
-
Rouba Hoteit, Sylvana Hassanieh, and Rami Mahfouz
- Subjects
Oncology ,medicine.medical_specialty ,Pediatrics ,Genotyping Techniques ,DNA Mutational Analysis ,Thrombophilia ,Tertiary care ,Internal medicine ,medicine ,Humans ,Methylenetetrahydrofolate Reductase (NADPH2) ,Genetics (clinical) ,Reagent Strips ,Polymorphism, Genetic ,biology ,business.industry ,Gene Expression Profiling ,Factor V ,General Medicine ,Factor ii ,medicine.disease ,Molecular Diagnostic Techniques ,Methylenetetrahydrofolate reductase ,biology.protein ,Prothrombin ,Reagent Kits, Diagnostic ,business - Abstract
Aims: To compare the performance of two assays used for the detection of mutations/polymorphisms in the Factor V, Factor II, and methylenetetrahydrofolate reductase genes among patients referred for the management of a thrombotic event. Materials and Methods: We tested 40 different patient samples using two assays, the ViennaLab FV-PTH-MTHFR StripAssay and the Cepheid Xpert HemosIL. Results: The two assays were 100% concordant in their produced results with no samples failing the testing procedures in both. Conclusion: This is the first report to evaluate the performance of the ViennaLab FV-PTH-MTHFR StripAssay and the Cepheid Xpert HemosIL. Both assays can be introduced to the operation of molecular diagnostic laboratories to cover the referrals from different disciplines, especially in tertiary care centers with emergency departments.
- Published
- 2014
- Full Text
- View/download PDF